News & publications.

Company milestones, the meetings where our team is presenting, and the peer-reviewed evidence base behind the platform. Our next stop is ASTRO 2026, in Boston, minutes from our Cambridge headquarters.

Meet us at ASTRO 2026.

Attending

ASTRO 68th Annual Meeting

American Society for Radiation Oncology

September 26 – 30, 2026 Boston, MA In person & virtual

Held at the Thomas M. Menino Convention & Exhibition Center under the theme "Data to Dialogue: Communicating Radiotherapy's Value to Advance Care."

ASTRO is the field's largest gathering of radiation oncologists, and it lands minutes from our Cambridge headquarters as we open US clinical and commercial entry for the ALBA platform. If your team will be there, we would like to connect.

Request a meeting › Meeting details ›

ASTRO 2026

Booth 1541

September 2026

26–30

Boston Convention District

Exhibits open daily, Sunday Sep 27 – Tuesday Sep 29

Five days at the center of radiation oncology.

Program details are drawn from ASTRO's published 2026 Annual Meeting information and are subject to change. Full schedule, registration and housing are available on the official ASTRO Annual Meeting portal.

The evidence base behind the platform.

A selection of peer-reviewed literature and most recent conference abstracts underpinning heat-activated precision oncology, from the mechanism of action to the randomized clinical evidence. It includes landmark Phase III trials co-authored by our scientific co-founder, Prof. Lars H. Lindner.

Selected references underpinning the mechanism and clinical rationale of the Avenor platform. Full citations and DOIs link to the publisher of record. This list is illustrative of the evidence base and is not an exhaustive bibliography.